Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Trevor Eisenberg"'
Autor:
Camila I. Irion, Monique Williams, Jose Condor Capcha, Trevor Eisenberg, Guerline Lambert, Lauro M. Takeuchi, Grace Seo, Keyvan Yousefi, Rosemeire Kanashiro-Takeuchi, Keith A. Webster, Karen C. Young, Joshua M. Hare, Lina A. Shehadeh
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6674 (2022)
Alport syndrome (AS) is a hereditary renal disorder with no etiological therapy. In the preclinical Col4a3-/- model of AS, disease progression and severity vary depending on mouse strain. The sodium-glucose cotransporter 2 (SGLT2) is emerging as an a
Externí odkaz:
https://doaj.org/article/fbf60d0410904b11b6dde6632eeaf219
Autor:
Michael, Dangl, Trevor, Eisenberg, Jelani K, Grant, Louis, Vincent, Rosario, Colombo, Rhea, Sancassani, Joao, Braghiroli, Paul, Martin, Rodrigo, Vianna, Ramona, Nicolau-Raducu, Cesar, Mendoza
Publikováno v:
Transplantation Reviews. 36:100709
The prevalence of coronary artery disease has increased in patients with end stage liver disease. In the near future, non-alcoholic steatohepatitis is expected to be the leading cause of end stage liver disease and shares common risk factors with cor
Autor:
Trevor Eisenberg, Kristopher A. Hendershot, Juan Lopez, Odunayo Olorunfemi, Mauricio G. Cohen
Publikováno v:
Journal of the American College of Cardiology. 79:2589
Publikováno v:
Journal of the American College of Cardiology
Autor:
Trevor Eisenberg, Carlos Alfonso, Roger G. Carrillo, Stephen M. Cresse, Donald Williams, Mauricio G. Cohen, Eduardo DeMarchena
Publikováno v:
Pacing and clinical electrophysiology : PACE. 42(7)
Background Complete heart block is a known complication after transcatheter aortic valve replacement (TAVR), often requiring pacemaker implantation within 24 hours of the procedure. However, clinical markers for delayed progression to complete heart
Autor:
Wen Ding, Mei Methawasin, Joshua M. Hare, Lina A. Shehadeh, Guerline Lambert, Henk Granzier, Dong I. Lee, David A. Kass, Keith A. Webster, Virginia S. Hahn, Keyvan Yousefi, Camila Iansen Irion, Sarah Sukkar, Trevor Eisenberg, Konstantinos E. Hatzistergos, Lauro M Takeuchi
Publikováno v:
Journal of the American College of Cardiology. 73(21)
Background Patients with chronic kidney disease (CKD) and coincident heart failure with preserved ejection fraction (HFpEF) may constitute a distinct HFpEF phenotype. Osteopontin (OPN) is a biomarker of HFpEF and predictive of disease outcome. We rec